02/02/2010
Peter C. Block, MD; Hiram G. Bezerra, MD, PhD; Emerson C. Perin, MD, PhD; Marco A. Costa, MD, PhD; Gary L. Schaer, MD, FACC, FSCAI; Stanley Katz, MD, FACC; Peter B. Berger, MD; Eric J. Dippel, MD; Stephen R. Ramee, MD; Sidney A. Cohen, MD, PhD; Mirle A. Kellett, MD; Suzanne Britto, RN
ABSTRACT: Objective. To examine the 1-year safety and clinical outcomes associated with the post-marketing early unselected use of sirolimus-eluting stents (SES) in the United States. Background. The safety and effectiveness of SES has been...
ABSTRACT: Objective. To examine the 1-year safety and clinical outcomes associated with the post-marketing early unselected use of sirolimus-eluting stents (SES) in the United States. Background. The safety and effectiveness of SES has been...
ABSTRACT: Objective. To examine...